A series of flavonolate complexes [M(II)L(fla)] (M = Mn (1), Fe (2), Co (3), Ni (4), Cu (5), and Zn (6), LH: 2-{[bis(pyridin-2-ylmethyl)amino]methyl}benzoic acid, fla: flavonolate) have been synthesized as structural and functional models for the ES (enzyme-substrate) complexes of the active site of various M(II)-containing quercetin 2,3-dioxygenase (2,3-QD) and their structures, spectroscopic features, and redox properties, as well as the reactivity toward molecular oxygen, have been investigated. The metal centers of [Fe(II)L(fla)]·H2O (2), [Co(II)L(fla)]·CH3OH (3), and [Ni(II)L(fla)] (4) exhibit a distorted octahedral geometry with two oxygen atoms of fla, one oxygen atom of the benzoate group of ligand L, and three nitrogen atoms of ligand L, in which oxygen atom of the carbonyl group of fla and one of the pyridine nitrogen atoms occupy the axial positions. The complexes [M(II)L(fla)] exhibit relatively high reactivity in the oxidative ring-opening of the bound flavonolate at lower temperature, presumably due to the existing carboxylate group in the supporting ligand. Thus, our complexes act as good functional ES models of various metal(II)-containing 2,3-QD. In addition, complexes [Fe(II)L(fla)]·H2O (2), [Co(II)L(fla)]·CH3OH (3), and [Ni(II)L(fla)] (4) are the first structurally characterized Fe(II)-, Co(II)-, and Ni(II)-flavonolate complexes, as an active site ES model of Fe(II)-, Co(II)-, and Ni(II)-containing 2,3-QD, respectively. The model complexes exhibit notably different reactivity in the order of Fe (2) > Cu (5) > Co (3) > Ni (4) > Zn (6) > Mn (1). The differences in the reactivity among them may be attributed to the redox potential of the coordinated flavonolate of the complexes, which are remarkably influenced by the Lewis acidity of the metal ion and its coordination environment. Our study is the first example of the metal ion effects on the enzyme-like dioxygenation reactivity, providing important insights into the metal ion effects on the enzymatic reactivity of various metal(II)-containing 2,3-QD.

A series of mononuclear Co(II)-flavonolate complexes [Co(II)L(R)(fla)] (L(R)H = 2-{[bis(pyridin-2-ylmethyl)amino]methyl}-p/m-R-benzoic acid; R = p-OMe (1), p-Me (2), m-Br (4), and m-NO2 (5); fla = flavonolate) were designed and synthesized as structural and functional models for the ES (enzyme-substrate) complexes to mimic the active site of the Co(II)-containing quercetin 2,3-dioxygenase (Co-2,3-QD). The metal center Co(II) ion in each complex shows a similar distorted octahedral geometry. The model complexes display high enzyme-type dioxygenation reactivity (oxidative O-heterocyclic ring opening of the coordinated substrate flavonolate) at low temperature, presumably due to the attached carboxylate group in the ligands. The reactivity exhibits a substituent group dependent order of -OMe (1) > -Me (2) > -H (3)14b > -Br (4) > -NO2 (5), and the Hammett plot is linear (ρ = -0.78). This can be explained as the electronic nature of the substituent group in the ligands may influence the conformation and redox potential of the bound flavonolate and finally bring different reactivity. The structures, properties, and reactivity of the model complexes show some dependence on the substituent group in the supporting model ligands, and there is some relationship among them. This study is the first example of a series of structural and functional ES models of Co-2,3-QD, with focus on the effects of the electronic nature of substituted groups and the carboxylate group of the ligands to the dioxygenation reactivity, that will provide important insights into the structure-property-reactivity relationship and the catalytic role of Co-2,3-QD.

Ni(II)-flavonolate complexes [Ni(II)L(R)(fla)] (L(R)H: 2-{[bis(pyridin-2-ylmethyl)amino]methyl}-p/m-R-benzoic acid, R: p-OMe (1), p-Me (2), m-Br (4) and m-NO2 (5), fla: flavonolate) were synthesized and characterized with relevance to structural and functional models for the ES (enzyme-substrate) adduct of the Ni(II)-containing quercetin 2,3-dioxygenase (2,3-QD). Their structures, spectroscopic features, redox properties and the reactivity toward molecular oxygen have been investigated. The complexes show a similar distorted octahedral structure and higher enzyme-type dioxygenation reactivity than other reported metal-flavonolate complexes in the oxidative O-heterocyclic ring-opening of the bound substrate flavonolate at lower temperature owing to the introduced carboxylate group in the supporting model ligands. The reaction rate shows first-order dependence on both of the complex and O2 and the second-order rate constant k fits a Hammett linear free energy relationship (ρ = -0.71) for the substituent group in the supporting model ligand L(R). The complexes exhibit substituent group dependent structures, properties and reactivity and there are some relationship among them, which could be ascribed to the electronic nature of the substituent group via the benzoate, Ni(II) ion and O(4)=C(27)-C(21)=C(22) "electron conduit". In a word, the stronger electron donating group could induce a smaller torsion angle, larger λ(max) and lower redox potential of the bound flavonolate, making a higher reactivity finally. This study is the first example of a series of structural and functional ES models of the Ni(II)-containing 2,3-QD, providing important insights into the structure-property-reactivity relationship, the electronic substituent effects and carboxylate effects on the enzymatic reactivity and the catalytic role of the Ni(II)-containing 2,3-QD.

In order to get insights into the metal ion effects and the carboxylate effects on enzymatic activity, a series of the carboxylate ligand supported transition metal complexes [M(II)L(OAc)] (M = Mn (), Fe (), Co (), Ni (), Cu () and Zn (); LH = 2-{[bis-(pyridin-2-ylmethyl)amino]methyl}-4-methoxy benzoic acid) were synthesized and characterized as structural and functional models for the active sites of various M(II)-substituted resting quercetin 2,3-dioxygenases (2,3-QD). Their structures, spectroscopic features, redox properties, as well as the catalytic reactivity toward the substrate flavonol and O2 have been investigated in detail. The model complexes show higher enzymatic reactivities in the catalytic dioxygenation (oxidative ring opening) of the substrate flavonol at lower temperatures (55-100 °C), presumably caused by the carboxylate group in the supporting model ligand, which could lower the redox potential of the bound substrate flavonolate by electron donation. The catalytic reactivity of [M(II)L(OAc)] exhibits notable differences and it is in a metal ion dependent order of Co () > Ni () > Zn () > Fe () > Mn () > Cu (). The differences in the reactivities among them could be ascribed to the redox potential of the bound substrate flavonolate, which was drastically influenced by the metal ions via tuning the electron density of flavonolate, providing important insights into the metal ion effects and the carboxylate effects on the enzymatic activity of various M(II)-substituted 2,3-QD. Our model complexes [M(II)L(OAc)] are the first examples of a series of structural and functional models of various M(II)-substituted resting 2,3-QD.

Budd-Chiari syndrome (BCS) is a vascular disorder characterized by obstruction of hepatic venous outflow from the hepatic venules to the entrance of the inferior vena cava (IVC) into the right atrium.1,2 In contrast to Western countries, IVC obstruction is a common cause of BCS in China. This disorder is classified into membranous obstruction of IVC (MOVC; obstructed segment of IVC is ≤1.0 cm) and segmental obstruction of IVC (SOVC; obstructed segment of IVC is >1.0 cm). [3][4][5][6] Treatments for this disorder include medical management, surgical operation, and endovascular intervention. Medical management alone has a limited ability to arrest progression of the disease, as reported in a study of 237 patients, where 72% failed to show a significant survival benefit.7 Surgery has been associated with high mortality rates (≤50%) and complicated by dysfunction rates as high as 32%. 8,9 Endovascular intervention has proven more effective than medical management and is associated with lower rates of mortality than open surgical procedures. [10][11][12] It has become the primary treatment of choice for BCS management in China because of its minimal invasiveness and good efficacy.Although several studies reported the safety and efficacy of endovascular intervention for the management of primary BCS caused by IVC obstruction, [13][14][15][16] few studies compared long-term outcomes of endovascular management between MOVC and SOVC patients. Moreover, there are still controversies about the optimal endovascular strategy for these conditions according to previous reports. 5,[13][14][15][16] Two previous studies showed that balloon dilation alone was sufficient in most BCS patients with MOVC and SOVC, and <3% had recurrence in 3 to 8 years of follow-up.5,13 However, otherBackground-Endovascular management is important for the treatment of primary Budd-Chiari syndrome, which is caused by inferior vena cava (IVC) obstruction. The aims of this study were to compare long-term outcomes of endovascular management for primary Budd-Chiari syndrome patients with membranous obstruction of IVC (MOVC) and segmental obstruction of IVC (SOVC) and explore the optimal endovascular strategy for these conditions. Methods and Results-Clinical data of 265 patients with Budd-Chiari syndrome who received endovascular management (MOVC group, n=136; SOVC group, n = 129) were retrospectively reviewed. Cumulative IVC patency rates were generated by the Kaplan-Meier method and compared by log-rank test. In total, 245 patients were followed up from 3 to 72 months after treatment. The difference of long-term outcomes of balloon dilation alone versus stent placement was not significant in each group. The overall cumulative 1-, 3-, and 5-year primary IVC patency rates were 98.3%, 90.7%, and 83.8% in the MOVC group and 88.3%, 79.1%, and 67.9% in the SOVC group (P=0.007), respectively. The long-term IVC patency rates were lower in the SOVC group than in the MOVC group for patients who underwent balloon dilation alone (P=0.001) and did not significantly d...